JNJ
JNJ
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

Johnson & Johnson

$245.84
+3.35 (+1.38%)
As of Feb 24, 1:03 PM ET ·
Analyst Consensus
Buy
32
Analysts
Very High
Coverage
Buy 19 59%
Hold 13 41%
Sell 0 0%
Price Target
Analyst Price Target +21.8% upside
Low Target $223.02
Average Target $299.55
High Target $400.15
Current Price $245.84
Current
$245.84
Target
$299.55
$223.02 $299.55 avg $400.15
Scenario Analysis
Bear Case
$223.02
-9.3%
Low target
Base Case
$299.55
+21.8%
Avg target
Bull Case
$400.15
+62.8%
High target
Risk/Reward
6.8x
Highly favorable
Price in Context
52-Week High
$246.96
-0.5% from high
52-Week Low
$141.50
+73.7% from low
50-Day SMA
$219.25
+12.1% vs SMA
200-Day SMA
$185.17
+32.8% vs SMA
RSI (14)
88.6
Overbought
Target vs 52W High
$299.55
+21.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Buy 37 73% $1,330.33 +25.7%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +21.8%
MRK
Merck & Co. Inc.
Buy 34 62% $159.27 +28.6%
PFE
Pfizer Inc.
Hold 33 45% $33.90 +25.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +184.9%
ZTS
Zoetis Inc
Buy 24 67% $209.87 +65.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -18.8%
VTRS
Viatris Inc
Buy 18 61% $122.82 +670.0%